单击此处阅读完整的文章。资料来源： 伊朗J公共卫生。 2022 Jun; 51（6）：1223-1231。 PMID： 36447978“> 36447978 Bahramvand, Elham Nasrollahi, Armin Salek Maghsoudi, Fatemeh Yazdi, Sepideh KarkonShayan, Shokoufeh Hassani Emad Jafarzadeh BACKGROUND: Irritable bowel syndrome （IBS）是一种高度普遍的肠道相互作用疾病，其特征是在没有结构异常的情况下与肠习惯改变有关的腹部不适和疼痛。尽管有IBS高流行率和全球疾病负担，没有关于其潜在的病理生理学的解释。至于IBS的治疗，没有特定的药物，最有益的治疗方法通常是支持治疗。 Recent animal and human studies have demonstrated the therapeutic potential of curcumin or turmeric in the treatment of IBS. METHODS: We systematically reviewed all available evidence supporting curcumin and turmerics therapeutic potential in relieving IBS symptoms in the present study. For this purpose, a database search was performed using curcumin, turmeric, and IBS and all their equivalents as of the search terms in Web of Science, Pub-Med, Scopus, Ovid, Embase, and Google Scholar from1990 up to Feb 2021. The investigation was then limited to clinical trials, and then nine articles were collected for data analysis. 结果： the included literature showed that curcumin and turmeric alone or in combination with other medications could improve the severity of IBS as well as the quality of life among people who suffer from IBS symptoms. CONCLUSION: Overall, medications containing curcumin and turmeric extract due to these compounds anti-inflammatory effects may improve IBS症状，尤其是腹痛和生活质量。